0001179110-13-003416.txt : 20130222 0001179110-13-003416.hdr.sgml : 20130222 20130222190358 ACCESSION NUMBER: 0001179110-13-003416 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130220 FILED AS OF DATE: 20130222 DATE AS OF CHANGE: 20130222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mammen Mathai CENTRAL INDEX KEY: 0001421050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 13635888 MAIL ADDRESS: STREET 1: THERAVANCE,INC. STREET 2: 901 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0306 4 2013-02-20 0 0001080014 THERAVANCE INC THRX 0001421050 Mammen Mathai THERAVANCE, INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP, Research & Early Clin Dev Common Stock 2013-02-20 4 F 0 5002 22.10 D 219976 D Common Stock 2013-02-20 4 S 0 7000 22.14 D 212976 D Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c). This transaction was executed in multiple trades at prices ranging from $21.99 to $22.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Heather M. Shane as Attorney-in-Fact 2013-02-22